drugset / Trial / NCT02009709

Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2

NCT02009709

Phase 1 Unknown 100 enrolled Robert Mack, M.D.
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to determine the effectiveness and safety of corneal collagen cross-linking at irradiance levels of 9 and 18 mW/cm2.

Timeline

Start
2013-10
Primary completion
2017-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified 0.1 % Other